Nomatropin is a human growth hormone (hGH) produced with recombinant DNA technology. Nomatropin is a highly purified protein with 191 amino acid residues. The amino acid sequence of the product is identical to that of pituitary derived human growth hormone. Biological potency is achieved by using a cell proliferation bioassay.
Nomatropin is a sterile, lyophilized powder intended for subcutaneous administration after reconstitution with bacteriostatic water for injection. The reconstituted product is nearly isotonic at a concentration of 4 mg/ml (10IU) growth hormone (rhGH) and has a pH of approximately 2.96. Each vial contains 4 mg (approximately 10 international units) of Nomatropin patented growth hormone formula, lyophilized with 45mg mannitol, 7.5mg sodium phosphates (0.9mg sodium phosphate monobasic and 6.6mg sodium phosphate dibasic), and 5mg glycine.
Nomatropin is indicated for the treatment of growth failure due to the lack of adequate endogenous GH secretion, growth failure associated with chronic renal insufficiency up to the time of renal transplantation, short stature associated with turner syndrome, and endogenous GH in patients with adult GH deficiency. Nomatropin is also indicated for those who are in severe catabolic states such as surgery, trauma, burns, organ failure or cancer to promote protein synthesis. Nomatropin is further indicated for the treatment of the congestive heart failure and osteoporosis, it increases and promotes sleep and in particular R.E.M. deep sleep, it decreases body fat and cellulite and improve skin texture and appearance by decreasing wrinkles.
A weekly dosage of 0.3mg per kilogram body weight divided into daily subcutaneous injections are recommended.
If an overdose is suspected contact your local doctor or hospital for assistance. Symptoms of overdose include headache, nausea, vomiting and bloating or swelling of the feet, ankles or hands.
Drug interactions can result in unwanted side effects or prevent a medicine from taking effect. Use our drug interaction checker to find out if our medicines interact negatively with other pharmaceuticals. Some medicines or medical conditions may interact with Nomatropin growth hormone. Inform your doctor or pharmacist of all prescription medicines or allergies. Use of this medicine is not recommended if you have a history of leukemia. Please contact your doctor or pharmacist if you have any questions or concerns regarding this medicine.
Possible side effects
Check with your doctor as soon as possible if you experience pain or stiffness in joints or redness, swelling and pain at the site of injecting. If you notice other side effects not mentioned above contact your doctor or pharmacist.
Keep all appointments with your doctor while using this medicine. If you have diabetes and use insulin this medicine may affect your blood sugar levels and in turn may effect your insulin requirements. Check your blood glucose levels closely and if Nomatropin affects it consult with your doctor before adjusting the dose of your insulin.
Before reconstitution Nomatropin must be stored at 2℃ – 8℃ refrigerated. Avoid freezing the vials when refrigerating it.
After reconstitution with bacteriostatic water Nomatropin will be stable for 72 hours at 2℃ – 8℃ when refrigerated. Avoid freezing the reconstituted vial of Nomatropin.
Expiration dates are stated on the boxes and labels.
For transportation and shipping purposes Nomatropin could be kept at 37℃ for up to 45 days successfully without it perishing.